PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
1.855
+0.035 (1.95%)
Nov 4, 2026, 9:39 AM EST - Market open
PAVmed Employees
PAVmed had 41 employees as of December 31, 2025. The number of employees increased by 2 or 5.13% compared to the previous year. That makes PAVmed the 35,838th largest employer in the world and 4,893rd in the United States.
Employees
41
Change (1Y)
2
Growth (1Y)
5.13%
Revenue / Employee
$2,732
Profits / Employee
-$503,098
Market Cap
12.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 41 | 2 | 5.13% | 41 | 0 |
| Dec 31, 2024 | 39 | -68 | -63.55% | 39 | 0 |
| Dec 31, 2023 | 107 | -17 | -13.71% | 107 | 0 |
| Dec 31, 2022 | 124 | 35 | 39.33% | 124 | 0 |
| Dec 31, 2021 | 89 | 64 | 256.00% | 89 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 809 |
| Cytosorbents | 129 |
| InspireMD | 127 |
| IRIDEX | 93 |
| Lifeward | 81 |
| Picard Medical | 75 |
| Pulsenmore | 71 |
| Modular Medical | 51 |
PAVM News
- 1 hour ago - Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PRNewsWire
- 1 day ago - Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study - PRNewsWire
- 5 days ago - PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026 - PRNewsWire
- 6 days ago - Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026 - PRNewsWire
- 12 days ago - Lucid Diagnostics begins receiving Medicare reimbursement for EsoGuard - TheFly
- 12 days ago - Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing - PRNewsWire
- 6 weeks ago - Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways - PRNewsWire
- 2 months ago - PAVmed price target raised to $57 from $56 at Ascendiant - TheFly